Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)

Jiangsu CoWin Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	184.21	255.47	348.34	1,032	127.83	38.84
Short-Term Investments	-	60.54	90.01	-	-	-
Trading Asset Securities	426.81	417.04	545.28	402.59	233.42	303.17
Cash & Short-Term Investments	611.02	733.05	983.64	1,434	361.25	342.01
Cash Growth	-6.48%	-25.48%	-31.41%	297.00%	5.63%	3525.14%
Accounts Receivable	75.37	43.28	58.96	129.64	36.56	25.94
Other Receivables	2.07	-	-	0.31	-	1.1
Receivables	77.44	43.28	58.96	129.95	36.56	27.04
Inventory	59.66	45.87	32.04	52.53	32.62	24.22
Other Current Assets	339.64	11.21	10.04	10.05	7.72	4.07
Total Current Assets	1,088	833.4	1,085	1,627	438.16	397.34
Property, Plant & Equipment	341.49	381.13	394.39	246.43	159.44	30.19
Long-Term Investments	19.2	296.81	256.71	-	-	-
Goodwill	1.08	1.08	-	4.27	-	-
Other Intangible Assets	47.96	49.97	29.77	29.35	30.15	0.65
Long-Term Deferred Tax Assets	34.75	32.5	29.83	17.11	4	5.67
Long-Term Deferred Charges	13.54	20.73	24.8	11.36	13.82	9.3
Other Long-Term Assets	5.06	2.52	2.04	20.06	3.2	2.49
Total Assets	1,551	1,618	1,822	1,955	648.77	445.64
Accounts Payable	22.32	31.86	47.53	44.07	10.55	5.41
Accrued Expenses	11.79	18.51	16.69	21.69	22.12	8.86
Short-Term Debt	10.01	6.01	-	-	-	-
Current Portion of Leases	7.01	12.12	13.65	9.05	5.67	-
Current Income Taxes Payable	0.34	-	-	9.56	8.21	1.97
Current Unearned Revenue	15.78	9.63	4.48	5.75	10.28	7.49
Other Current Liabilities	8.65	5.87	2.51	3.03	3.58	2.14
Total Current Liabilities	75.9	84	84.86	93.15	60.41	25.86
Long-Term Leases	5.23	9.71	19.31	31.72	34.33	-
Long-Term Unearned Revenue	54.21	30.25	30.11	29.58	5.67	5.52
Long-Term Deferred Tax Liabilities	6.22	7.75	8.32	9.1	0.06	0.24
Other Long-Term Liabilities	0.13	0.09	0.06	0.05	0.04	0.03
Total Liabilities	141.69	131.79	142.67	163.6	100.51	31.65
Common Stock	112.49	112.49	112.23	93.52	69.87	69.87
Additional Paid-In Capital	1,399	1,394	1,391	1,393	344.45	336.02
Retained Earnings	-73.29	2.87	160.08	293.13	133.87	8.02
Treasury Stock	-47.67	-43.66	-	-	-	-
Comprehensive Income & Other	0.33	0.33	0.3	0.27	0.07	0.09
Total Common Equity	1,391	1,466	1,664	1,780	548.26	414
Minority Interest	18.62	20.56	15.88	11.31	-	-
Shareholders' Equity	1,409	1,486	1,680	1,792	548.26	414
Total Liabilities & Equity	1,551	1,618	1,822	1,955	648.77	445.64
Total Debt	22.25	27.84	32.95	40.77	39.99	-
Net Cash (Debt)	588.77	705.21	950.68	1,393	321.25	342.01
Net Cash Growth	-4.96%	-25.82%	-31.77%	333.73%	-6.07%	3525.14%
Net Cash Per Share	5.31	6.32	8.45	15.00	3.81	4.89
Filing Date Shares Outstanding	109.93	110.11	112.49	112.23	83.85	83.85
Total Common Shares Outstanding	109.93	110.11	112.23	112.23	83.85	83.85
Working Capital	1,012	749.41	999.82	1,534	377.75	371.48
Book Value Per Share	12.65	13.31	14.82	15.86	6.54	4.94
Tangible Book Value	1,341	1,415	1,634	1,747	518.11	413.35
Tangible Book Value Per Share	12.20	12.85	14.56	15.56	6.18	4.93
Buildings	-	235.28	234.89	0.66	0.66	0.66
Machinery	-	207.97	188.41	133.11	75.91	40.96
Construction In Progress	-	0.37	-	110.9	64.81	0.61

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.